vs
アジレント・テクノロジー（A）とAddus HomeCare Corp（ADUS）の財務データ比較。上の社名をクリックして会社を切り替えられます
アジレント・テクノロジーの直近四半期売上が大きい（$1.8B vs $373.1M、Addus HomeCare Corpの約4.8倍）。アジレント・テクノロジーの純利益率が高く（17.0% vs 8.0%、差は9.0%）。Addus HomeCare Corpの前年同期比売上増加率が高い（25.6% vs 7.0%）。アジレント・テクノロジーの直近四半期フリーキャッシュフローが多い（$175.0M vs $16.1M）。過去8四半期でAddus HomeCare Corpの売上複合成長率が高い（15.3% vs 6.9%）
アジレント・テクノロジーはライフサイエンス、診断、応用化学分野向けのソリューションを世界中で提供する企業です。ライフサイエンス・応用市場部門は液体クロマトグラフィーシステム、質量分析計、ガスクロマトグラフィー、誘導結合プラズマ質量分析装置、原子吸光光度計などの分析機器を展開しています。
Addus HomeCare Corpは米国に本拠を置く在宅ケアサービスプロバイダーで、高齢者、障がい者、慢性疾患患者を主な対象に、介護補助、在宅医療支援、ホスピスケアを提供しています。米国複数州で事業を展開し、公的保険運営元、民間保険会社、個人顧客と提携してニーズに合わせたサービスを届けています。
A vs ADUS — 直接比較
損益計算書 — Q1 2026 vs Q4 2025
| 指標 | | |
|---|---|---|
| 売上 | $1.8B | $373.1M |
| 純利益 | $305.0M | $29.8M |
| 粗利率 | 52.6% | 33.1% |
| 営業利益率 | 19.6% | 11.3% |
| 純利益率 | 17.0% | 8.0% |
| 売上前年比 | 7.0% | 25.6% |
| 純利益前年比 | -4.1% | 52.5% |
| EPS（希薄化後） | $1.07 | $1.62 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q1 26 | $1.8B | — | ||
| Q4 25 | $1.9B | $373.1M | ||
| Q3 25 | $1.7B | $362.3M | ||
| Q2 25 | $1.7B | $349.4M | ||
| Q1 25 | $1.7B | $337.7M | ||
| Q4 24 | $1.7B | $297.1M | ||
| Q3 24 | $1.6B | $289.8M | ||
| Q2 24 | $1.6B | $286.9M |
| Q1 26 | $305.0M | — | ||
| Q4 25 | $434.0M | $29.8M | ||
| Q3 25 | $336.0M | $22.8M | ||
| Q2 25 | $215.0M | $22.1M | ||
| Q1 25 | $318.0M | $21.2M | ||
| Q4 24 | $351.0M | $19.5M | ||
| Q3 24 | $282.0M | $20.2M | ||
| Q2 24 | $308.0M | $18.1M |
| Q1 26 | 52.6% | — | ||
| Q4 25 | 53.2% | 33.1% | ||
| Q3 25 | 51.1% | 32.2% | ||
| Q2 25 | 51.9% | 32.6% | ||
| Q1 25 | 53.5% | 31.9% | ||
| Q4 24 | 53.9% | 34.2% | ||
| Q3 24 | 54.2% | 31.8% | ||
| Q2 24 | 54.4% | 32.5% |
| Q1 26 | 19.6% | — | ||
| Q4 25 | 23.8% | 11.3% | ||
| Q3 25 | 20.7% | 9.1% | ||
| Q2 25 | 18.0% | 9.4% | ||
| Q1 25 | 22.4% | 9.0% | ||
| Q4 24 | 24.0% | 9.1% | ||
| Q3 24 | 21.1% | 9.0% | ||
| Q2 24 | 23.1% | 9.1% |
| Q1 26 | 17.0% | — | ||
| Q4 25 | 23.3% | 8.0% | ||
| Q3 25 | 19.3% | 6.3% | ||
| Q2 25 | 12.9% | 6.3% | ||
| Q1 25 | 18.9% | 6.3% | ||
| Q4 24 | 20.6% | 6.6% | ||
| Q3 24 | 17.9% | 7.0% | ||
| Q2 24 | 19.6% | 6.3% |
| Q1 26 | $1.07 | — | ||
| Q4 25 | $1.53 | $1.62 | ||
| Q3 25 | $1.18 | $1.24 | ||
| Q2 25 | $0.75 | $1.20 | ||
| Q1 25 | $1.11 | $1.16 | ||
| Q4 24 | $1.23 | $1.06 | ||
| Q3 24 | $0.97 | $1.10 | ||
| Q2 24 | $1.05 | $1.10 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $1.8B | — |
| 総負債低いほど良い | $3.0B | $121.0M |
| 株主資本純資産 | $6.9B | $1.1B |
| 総資産 | $12.8B | $1.4B |
| 負債/資本比率低いほどレバレッジが低い | 0.44× | 0.11× |
8四半期トレンド — 暦四半期で整列
| Q1 26 | $1.8B | — | ||
| Q4 25 | $1.8B | — | ||
| Q3 25 | $1.5B | — | ||
| Q2 25 | $1.5B | — | ||
| Q1 25 | $1.5B | $97.0M | ||
| Q4 24 | $1.3B | $98.9M | ||
| Q3 24 | $1.8B | $222.9M | ||
| Q2 24 | $1.7B | $173.3M |
| Q1 26 | $3.0B | — | ||
| Q4 25 | $3.0B | $121.0M | ||
| Q3 25 | $3.4B | $150.6M | ||
| Q2 25 | $3.3B | $169.1M | ||
| Q1 25 | $3.3B | — | ||
| Q4 24 | $3.3B | $218.4M | ||
| Q3 24 | $2.1B | — | ||
| Q2 24 | $2.1B | — |
| Q1 26 | $6.9B | — | ||
| Q4 25 | $6.7B | $1.1B | ||
| Q3 25 | $6.4B | $1.0B | ||
| Q2 25 | $6.1B | $1.0B | ||
| Q1 25 | $6.0B | $995.4M | ||
| Q4 24 | $5.9B | $970.5M | ||
| Q3 24 | $5.9B | $947.6M | ||
| Q2 24 | $6.2B | $921.7M |
| Q1 26 | $12.8B | — | ||
| Q4 25 | $12.7B | $1.4B | ||
| Q3 25 | $12.2B | $1.4B | ||
| Q2 25 | $12.2B | $1.4B | ||
| Q1 25 | $11.9B | $1.4B | ||
| Q4 24 | $11.8B | $1.4B | ||
| Q3 24 | $11.0B | $1.2B | ||
| Q2 24 | $10.9B | $1.1B |
| Q1 26 | 0.44× | — | ||
| Q4 25 | 0.45× | 0.11× | ||
| Q3 25 | 0.53× | 0.14× | ||
| Q2 25 | 0.55× | 0.17× | ||
| Q1 25 | 0.56× | — | ||
| Q4 24 | 0.57× | 0.23× | ||
| Q3 24 | 0.36× | — | ||
| Q2 24 | 0.34× | — |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $268.0M | $18.8M |
| フリーキャッシュフロー営業CF - 設備投資 | $175.0M | $16.1M |
| FCFマージンFCF / 売上 | 9.7% | 4.3% |
| 設備投資強度設備投資 / 売上 | 5.2% | 0.7% |
| キャッシュ転換率営業CF / 純利益 | 0.88× | 0.63× |
| 直近12ヶ月FCF直近4四半期 | $993.0M | $103.8M |
8四半期トレンド — 暦四半期で整列
| Q1 26 | $268.0M | — | ||
| Q4 25 | $545.0M | $18.8M | ||
| Q3 25 | $362.0M | $51.3M | ||
| Q2 25 | $221.0M | $22.5M | ||
| Q1 25 | $431.0M | $18.9M | ||
| Q4 24 | $481.0M | $10.4M | ||
| Q3 24 | $452.0M | $48.5M | ||
| Q2 24 | $333.0M | $18.8M |
| Q1 26 | $175.0M | — | ||
| Q4 25 | $452.0M | $16.1M | ||
| Q3 25 | $259.0M | $49.3M | ||
| Q2 25 | $107.0M | $21.3M | ||
| Q1 25 | $334.0M | $17.1M | ||
| Q4 24 | $388.0M | $8.7M | ||
| Q3 24 | $360.0M | $46.6M | ||
| Q2 24 | $230.0M | $17.7M |
| Q1 26 | 9.7% | — | ||
| Q4 25 | 24.3% | 4.3% | ||
| Q3 25 | 14.9% | 13.6% | ||
| Q2 25 | 6.4% | 6.1% | ||
| Q1 25 | 19.9% | 5.1% | ||
| Q4 24 | 22.8% | 2.9% | ||
| Q3 24 | 22.8% | 16.1% | ||
| Q2 24 | 14.6% | 6.2% |
| Q1 26 | 5.2% | — | ||
| Q4 25 | 5.0% | 0.7% | ||
| Q3 25 | 5.9% | 0.5% | ||
| Q2 25 | 6.8% | 0.4% | ||
| Q1 25 | 5.8% | 0.6% | ||
| Q4 24 | 5.5% | 0.6% | ||
| Q3 24 | 5.8% | 0.7% | ||
| Q2 24 | 6.5% | 0.4% |
| Q1 26 | 0.88× | — | ||
| Q4 25 | 1.26× | 0.63× | ||
| Q3 25 | 1.08× | 2.24× | ||
| Q2 25 | 1.03× | 1.02× | ||
| Q1 25 | 1.36× | 0.89× | ||
| Q4 24 | 1.37× | 0.53× | ||
| Q3 24 | 1.60× | 2.41× | ||
| Q2 24 | 1.08× | 1.04× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
A
| Service Other | $525.0M | 29% |
| Chemicaland Energy Market | $422.0M | 23% |
| Agilent Cross Lab | $273.0M | 15% |
| Environmentaland Forensics Market | $177.0M | 10% |
| Food Market | $166.0M | 9% |
| Academiaand Government Market | $130.0M | 7% |
| Applied Markets | $98.0M | 5% |
ADUS
| Personal Care | $286.0M | 77% |
| Hospice | $70.0M | 19% |
| Home Health | $17.1M | 5% |
